Related Experiment Video
Updated: Jan 16, 2026

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
Cancer Biomarkers: Reflection on Recent Progress, Emerging Innovations, and the Clinical Horizon
M Walid Qoronfleh1,2,3, Nader Al-Dewik4,5,6
1Healthcare Research & Policy Division, Q3 Research Institute (QRI), Ypsilanti, MI 48917, USA.
None:
This perspective provides a short overview of cancer biomarkers, balancing the technical details with the broad implications for biomarker discovery and innovation; early detection and screening; personalized treatment and monitoring; and emerging technologies. It also briefly discusses challenges in their clinical translation while exploring recent advancements and future implications for clinical practice. Finally, we offer thoughts on the role of artificial intelligence (AI) in biomarker development. AI is accelerating the discovery and validation of biomarkers by mining complex datasets, identifying hidden patterns, and improving the predictive accuracy. AI-powered tools enhance image-based diagnostics, automate genomic interpretation, and facilitate real-time monitoring of treatment responses. By integrating multi-omics data, AI offers new avenues for precision medicine and scalable cancer diagnostics, pushing biomarker development into a new era of intelligent, data-driven oncology. This editorial is a reflection on the state of biomarkers based on the contributions to the Special Issue "Cancer Biomarkers: Recent Progress, Innovations, and Future Clinical Implications".
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer
Cancer Survival Analysis
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

